Michael Singer - 19 Nov 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role
Director
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Michael Singer
Issuer symbol
RNAC
Transactions as of
19 Nov 2024
Net transactions value
$0
Form type
4
Filing time
21 Nov 2024, 18:51:39 UTC
Previous filing
10 Apr 2024
Next filing
30 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Gift $0 -28,821 -24% $0.000000 90,933 19 Nov 2024 Direct
holding RNAC Common Stock 383,796 19 Nov 2024 by trust F1
holding RNAC Common Stock 56,719 19 Nov 2024 by trust F2
holding RNAC Common Stock 7,127 19 Nov 2024 by trust F3
holding RNAC Common Stock 14,788 19 Nov 2024 by spouse F4
holding RNAC Common Stock 96,219 19 Nov 2024 as custodian F5
holding RNAC Common Stock 96,219 19 Nov 2024 as custodian F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is a trustee of this trust.
F2 Shares are held in a trust for which the reporting person is a beneficiary. The reporting person is a trustee of this trust.
F3 Shares are held in a trust for which the reporting person is a beneficiary. The reporting person's spouse is a trustee of this trust.
F4 Shares are held by the reporting person's spouse.
F5 The shares are held for LS, the child of the reporting person, through a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA") for which the reporting person serves as custodian.
F6 The shares are held for SS, the child of the reporting person, through a custodial account established pursuant to the UTMA for which the reporting person serves as custodian.